Navigation Links
Grunenthal Group Acquires Pain Patent Portfolio From Nectid, Inc.
Date:3/22/2011

PRINCETON, N.J., March 22, 2011 /PRNewswire/ -- Nectid, Inc. (www.nectid.com) announced today that it has completed the sale of a number of patents and patents-applications to Grunenthal GmbH (www.grunenthal.com), a European specialty pharmaceutical company that is a pioneer in pain drug discovery and research. The patent portfolio includes a number of novel chemical entities from Nectid's Pain Drug Discovery program and two key drug delivery platforms (www.nectid.com/pipeline_newdrug).

Dr. Veena Rao, President and CEO of Nectid, said, "We are very happy with this patent sale transaction with Grunenthal. This is the second patent deal Nectid has completed in the last 12 months and the patents are among the nineteen of our patents that have been acquired by big pharmaceutical companies in the last two years. We have accumulated a portfolio of 110 NCEs for pain and depression and we expect to file an IND for at least one drug candidate within the next 6-9 months."

About Nectid, Inc.

Based in Princeton, New Jersey, Nectid is a privately held drug discovery company with primary focus on developing novel drug delivery products and novel chemical entities for two therapeutic areas that use one or more common biochemical pathways- Pain and Depression. Nectid applies its deep understanding pain receptor science to develop novel drug candidates that target mu-opioid receptor, norepinephrine reuptake and alpha2delta or NMDA pathways. For more information, visit www.nectid.com.


'/>"/>
SOURCE Nectid, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Introducing the Access Group and Its New Business Entities
2. MiMedx Group, Inc. to Present at the 10th Annual Needham Healthcare Conference
3. PR Newswire and BIOCOM Purchasing Group Announce Renewal of Exclusive Partnership
4. Apexigen Announces the Filing by its Partner, Simcere Pharmaceutical Group, of First IND
5. BioNeutral Group Secures Three Initial Trial Orders for its Ogiene™ Odor Neutralizer & Multi-Purpose Cleaner Product Line
6. Photonic Products Group, Inc. Announces New Sales and Marketing VP
7. NeoStem to Present at Cowen Group 31st Annual Health Care Conference on March 7 and 8
8. Healthzone Limited Engages The Trout Group for Investor Relations Services
9. BioNeutral Group to Receive Economic Development Incentives
10. 74 Percent EBITDA Improvement at Zeltia Group in 2010
11. Polaris Group and The Ludwig Institute for Cancer Research Ltd Initiate Phase 2 Trial of Amino-Acid Degrading Enzyme, ADI-PEG 20, in Patients with Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, ... microbial test has received AOAC Research Institute approval 061601. , “This is another ... year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel ...
(Date:6/23/2016)...   EpiBiome , a precision microbiome engineering company, ... financing from Silicon Valley Bank (SVB). The financing will ... its drug development efforts, as well as purchase additional ... has been an incredible strategic partner to us – ... would provide," said Dr. Aeron Tynes Hammack , ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published ... how a patient who developed lymphedema after being treated for breast cancer benefitted from ... the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
Breaking Biology Technology:
(Date:5/3/2016)...  Neurotechnology, a provider of high-precision biometric identification ... Identification System (ABIS) , a complete system for ... can process multiple complex biometric transactions with high ... face or iris biometrics. It leverages the core ... MegaMatcher Accelerator , which have been used in ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
(Date:3/31/2016)... Florida , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange ... potential users of its soon to be launched online ... ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential ... use of DNA technology to an industry that is ...
Breaking Biology News(10 mins):